1f3f

From Proteopedia
Revision as of 16:45, 15 February 2008 by OCA (talk | contribs)
Jump to navigation Jump to search
File:1f3f.jpg


1f3f, resolution 1.85Å

Drag the structure with the mouse to rotate

STRUCTURE OF THE H122G NUCLEOSIDE DIPHOSPHATE KINASE / D4T-TRIPHOSPHATE.MG COMPLEX

OverviewOverview

AIDS chemotherapy is limited by inadequate intracellular concentrations of, the active triphosphate form of nucleoside analogues, leading to, incomplete inhibition of viral replication and the appearance of, drug-resistant virus. Drug activation by nucleoside diphosphate kinase and, inhibition of HIV-1 reverse transcriptase were studied comparatively. We, synthesized analogues with a borano (BH(3)(-)) group on the, alpha-phosphate, and found that they are substrates for both enzymes., X-ray structures of complexes with nucleotide diphosphate kinase provided, a structural basis for their activation. The complex with d4T triphosphate, displayed an intramolecular CH.O bond contributing to catalysis, and the, R(p) diastereoisomer of thymidine alpha-boranotriphosphate bound like a, normal substrate. Using alpha-(R(p))-boranophosphate derivatives of the, clinically relevant compounds AZT and d4T, the presence of the, alpha-borano group improved both phosphorylation by nucleotide diphosphate, kinase and inhibition of reverse transcription. Moreover, repair of, blocked DNA chains by pyrophosphorolysis was reduced significantly in, variant reverse transcriptases bearing substitutions found in, drug-resistant viruses. Thus, the alpha-borano modification of analogues, targeting reverse transcriptase may be of generic value in fighting viral, drug resistance.

About this StructureAbout this Structure

1F3F is a Single protein structure of sequence from Dictyostelium discoideum with , , and as ligands. Active as Nucleoside-diphosphate kinase, with EC number 2.7.4.6 Full crystallographic information is available from OCA.

ReferenceReference

Structural basis for activation of alpha-boranophosphate nucleotide analogues targeting drug-resistant reverse transcriptase., Meyer P, Schneider B, Sarfati S, Deville-Bonne D, Guerreiro C, Boretto J, Janin J, Veron M, Canard B, EMBO J. 2000 Jul 17;19(14):3520-9. PMID:10899107

Page seeded by OCA on Fri Feb 15 15:45:37 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA